Yolanda Armero

1.3k total citations
14 papers, 465 citations indexed

About

Yolanda Armero is a scholar working on Infectious Diseases, Epidemiology and Public Health, Environmental and Occupational Health. According to data from OpenAlex, Yolanda Armero has authored 14 papers receiving a total of 465 indexed citations (citations by other indexed papers that have themselves been cited), including 14 papers in Infectious Diseases, 14 papers in Epidemiology and 6 papers in Public Health, Environmental and Occupational Health. Recurrent topics in Yolanda Armero's work include Antimicrobial Resistance in Staphylococcus (14 papers), Infective Endocarditis Diagnosis and Management (14 papers) and Streptococcal Infections and Treatments (6 papers). Yolanda Armero is often cited by papers focused on Antimicrobial Resistance in Staphylococcus (14 papers), Infective Endocarditis Diagnosis and Management (14 papers) and Streptococcal Infections and Treatments (6 papers). Yolanda Armero collaborates with scholars based in Spain, Switzerland and United States. Yolanda Armero's co-authors include Asunción Moreno, Francesc Marco, Carlos A. Mestres, Ana del Rı́o, Manel Almela, Dolors Soy, Carlos Falces, Carlos Cervera, José M. Gatell and C. García-de-la-Mària and has published in prestigious journals such as PLoS ONE, Antimicrobial Agents and Chemotherapy and Journal of Antimicrobial Chemotherapy.

In The Last Decade

Yolanda Armero

14 papers receiving 457 citations

Peers

Countries citing papers authored by Yolanda Armero

Since Specialization

Citations

This map shows the geographic impact of Yolanda Armero's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Yolanda Armero with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Yolanda Armero more than expected).

Fields of papers citing papers by Yolanda Armero

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Yolanda Armero. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Yolanda Armero. The network helps show where Yolanda Armero may publish in the future.

Co-authorship network of co-authors of Yolanda Armero

This figure shows the co-authorship network connecting the top 25 collaborators of Yolanda Armero. A scholar is included among the top collaborators of Yolanda Armero based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Yolanda Armero. Yolanda Armero is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

14 of 14 papers shown

#	Work	Indexed citations
1	Early in vitro development of daptomycin non-susceptibility in high-level aminoglycoside-resistant Enterococcus faecalis predicts the efficacy of the combination of high-dose daptomycin plus ampicillin in an in vivo model of experimental endocarditis 2017 ·Journal of Antimicrobial Chemotherapy ·Juan M. Pericàs, C. García-de-la-Mària, Merçè Brunet, Yolanda Armero, J. A. García-González, Gregori Casals, Manel Almela, Eduard Quintana, Carlos Falces, Salvador Pié i Ninot, David Fuster, Juan Llopis, Francesc Marco, Asunción Moreno, José M. Miró	14
2	AUC/MIC Pharmacodynamic Target Is Not a Good Predictor of Vancomycin Efficacy in Methicillin-Resistant Staphylococcus aureus Experimental Endocarditis 2017 ·Antimicrobial Agents and Chemotherapy ·Ximena Castañeda, C. García-de-la-Mària, Oriol Gasch, Juan M. Pericàs, Yolanda Armero, Dolors Soy, Javier García‐González, Carlos Falces, Salvador Pié i Ninot, Manel Almela, Juan Ambrosioni, Eduard Quintana, Bárbara Vidal, David Fuster, Jaume Llopis, Sara M. Soto, Asunción Moreno, Francesc Marco, José M. Miró	7
3	Impact of High-Level Daptomycin Resistance in the Streptococcus mitis Group on Virulence and Survivability during Daptomycin Treatment in Experimental Infective Endocarditis 2017 ·Antimicrobial Agents and Chemotherapy ·C. García-de-la-Mària, Yan Q. Xiong, Juan M. Pericàs, Yolanda Armero, Asunción Moreno, Nagendra N. Mishra, Michael J. Rybak, Truc T. Tran, César A. Arias, Paul M. Sullam, Arnold S. Bayer, José M. Miró	11
4	Fosfomycin plus β-Lactams as Synergistic Bactericidal Combinations for Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus 2015 ·Antimicrobial Agents and Chemotherapy ·Ana del Rı́o, C. García-de-la-Mària, José M. Entenza, Oriol Gasch, Yolanda Armero, Dolors Soy, Carlos A. Mestres, Juan M. Pericàs, Carlos Falces, Salvador Pié i Ninot, Manel Almela, Carlos Cervera, José M. Gatell, Asunción Moreno, Philippe Moreillon, Francesc Marco, (unknown)	27
5	Epidemiology and Prognosis of Coagulase-Negative Staphylococcal Endocarditis: Impact of Vancomycin Minimum Inhibitory Concentration 2015 ·PLoS ONE ·Cristina García de la Mària, Carlos Cervera, Juan M. Pericàs, Ximena Castañeda, Yolanda Armero, Dolors Soy, Manel Almela, Salvador Pié i Ninot, Carlos Falces, Carlos A. Mestres, José M. Gatell, Asunción Moreno, Francesc Marco, José M. Miró	20
6	Changes in the treatment of Enterococcus faecalis infective endocarditis in Spain in the last 15 years: from ampicillin plus gentamicin to ampicillin plus ceftriaxone 2014 ·Clinical Microbiology and Infection ·Juan M. Pericàs, Carlos Cervera, Ana del Rı́o, Asunción Moreno, Cristina García de la Mària, Manel Almela, Carlos Falces, Salvador Pié i Ninot, Ximena Castañeda, Yolanda Armero, Dolors Soy, José M. Gatell, Francesc Marco, Carlos A. Mestres, J. M. Miró	66
7	Early In Vitro and In Vivo Development of High-Level Daptomycin Resistance Is Common in Mitis Group Streptococci after Exposure to Daptomycin 2013 ·Antimicrobial Agents and Chemotherapy ·C. García-de-la-Mària, Juan M. Pericàs, Ana del Rı́o, Ximena Castañeda, Xavier Vila‐Farrés, Yolanda Armero, Paula Espinal, Carlos Cervera, Dolors Soy, Carlos Falces, Salvador Pié i Ninot, Manel Almela, Carlos A. Mestres, José M. Gatell, Jordi Vilà, Asunción Moreno, Francesc Marco, José M. Miró	44
8	High-Dose Daptomycin plus Fosfomycin Is Safe and Effective in Treating Methicillin-Susceptible and Methicillin-Resistant Staphylococcus aureus Endocarditis 2012 ·Antimicrobial Agents and Chemotherapy ·José M. Miró, José M. Entenza, Ana del Rı́o, María Velasco, Ximena Castañeda, Cristina García de la Mària, Marlyse Giddey, Yolanda Armero, Juan M. Pericàs, Carlos Cervera, Carlos A. Mestres, Manuel Almela, Carlos Falces, Francesc Marco, Philippe Moreillon, Asunción Moreno	90
9	Daptomycin Is Effective for Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus epidermidis 2010 ·Antimicrobial Agents and Chemotherapy ·C. García-de-la-Mària, Francesc Marco, Yolanda Armero, Dolors Soy, Asunción Moreno, Ana del Rı́o, Manel Almela, Carlos Cervera, Salvador Pié i Ninot, Carlos Falces, Carlos A. Mestres, José M. Gatell, M. T. Jiménez de Anta, (unknown)	44
10	Addition of Gentamicin or Rifampin Does Not Enhance the Effectiveness of Daptomycin in Treatment of Experimental Endocarditis Due to Methicillin-Resistant Staphylococcus aureus 2009 ·Antimicrobial Agents and Chemotherapy ·J. M. Miró, C. García-de-la-Mària, Yolanda Armero, Dolors Soy, Asunción Moreno, Ana del Rı́o, Manel Almela, M. Arraiza, Carlos A. Mestres, José M. Gatell, M. T. Jiménez de Anta, Francesc Marco	47
11	047 DAPTOMYCIN IN THE TREATMENT OF EXPERIMENTAL ENDOCARDITIS (EE) DUE TO METHICILLIN-RESISTANT STAPHYLOCOCCUS EPIDERMIDIS (MRSE) 2009 ·International Journal of Antimicrobial Agents ·Cristina García de la Mària, Yolanda Armero, Dolors Soy, (unknown), Alejandro del Río, Manel Almela, Carlos A. Mestres, Carlos Cervera, Carlos Falces, Salvador Pié i Ninot, José M. Gatell, (unknown), Marco Fiorillo, (unknown)	1
12	Success of ampicillin plus ceftriaxone rescue therapy for a relapse of Enterococcus faecalis native-valve endocarditis and in vitro data on double beta-lactam activity 2008 ·Scandinavian Journal of Infectious Diseases ·José M. Miró, Carlos Cervera, C. García-de-la-Mària, Ana del Rı́o, Yolanda Armero, Carlos A. Mestres, (unknown), Francesc Marco, Asunción Moreno, (unknown)	10
13	Daptomycin Is Effective in Treatment of Experimental Endocarditis Due to Methicillin-Resistant and Glycopeptide-Intermediate Staphylococcus aureus 2008 ·Antimicrobial Agents and Chemotherapy ·Francesc Marco, Cristina García de la Mària, Yolanda Armero, (unknown), Dolors Soy, Asunción Moreno, Ana del Rı́o, Manel Almela, Carlos A. Mestres, José M. Gatell, M. T. Jiménez de Anta, José M. Miró	44
14	Efficacy of Telavancin in the Treatment of Experimental Endocarditis Due to Glycopeptide-Intermediate Staphylococcus aureus 2007 ·Antimicrobial Agents and Chemotherapy ·José M. Miró, C. García-de-la-Mària, Yolanda Armero, Elisa de Lazzari, Dolors Soy, Asunción Moreno, Ana del Rı́o, Manel Almela, Carlos A. Mestres, José M. Gatell, (unknown), Francesc Marco	40

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact